LOS ANGELES (JTA) — A Tel Aviv University graduate has won a top Student Academy Award and her documentary will be automatically entered in the Academy Awards competition.
Maya Sarfaty will also receive a gold medal for her film, “The Most Beautiful Woman,” it was announced Monday by the Academy of Motion Picture Arts and Sciences.
Beneath the appealing title lies the story of a love affair between an SS guard and a young Jewish woman at the Auschwitz death camp.
Among the list of nominees, Sarfaty’s film was the only one to make the cut in the foreign documentary category and is therefore guaranteed a gold medal when the final winners are announced on Sept. 22.
A native of Netanya, Sarfaty earned an undergraduate and master’s degree at the Steve Tisch School of Film and Television at Tel Aviv University and also graduated from the Nissan Nativ Acting School, which conducts classes in Jerusalem and Tel Aviv.
“The Most Beautiful Woman” is based on the actual story of Franz Wunsch, the guard who fell in love with Helena Citronova, a prisoner from Slovakia. In return for Citronova’s affection and sexual favors, Wunsch saves her and her sister Rosinka from certain death, though he is unable to save Rosinka’s two children.
In all, the academy selected 17 students as nominees in seven categories. All the nominees will be flown to Los Angeles one week before the award ceremony for seven days of studio activities and networking events.
Sarfaty now lists herself as an independent filmmaker who has earned credits as director, writer and/or editor for such films as “Still Waters” and “Overtime.”
An academy spokesperson said this year saw a record number of entries, with 1,749 films submitted by U.S. students and 95 films from colleges and universities in other countries.
The 89th Academy Awards gala is scheduled for Feb. 26, 2017.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.